|Global Blood Therapeutics Inc -- USA Stock|| |
USD 32 0.55 1.69%
Founder and AdvisorWe currently do not have informatin regarding Matthew Jacobson. This executive tanure with Global Blood Therapeutics Inc is not currenlty determined.
The company has Return on Asset of (22.45) %
which means that on every $100 spent on asset it lost $22.45. This is way below average. In the same way, it shows return on shareholders equity (ROE)
of (37.85) %
meaning that it generated no profit with money invested by stockholders.
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous bloodbased disorders. Global Blood Therapeutics Inc (GBT) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 55 people. Global Blood is listed under Pharmaceutical Products category by Fama And French industry classification.